{"id":"https://openalex.org/W7216346331","doi":"https://doi.org/10.3389/fimmu.2026.1844972","title":"Split intein-mediated reconstitution of regulatable CAR T-cells","display_name":"Split intein-mediated reconstitution of regulatable CAR T-cells","alternate_titles":[],"publication_year":2026,"publication_date":"2026-10-02","ids":{"openalex":"https://openalex.org/W7216346331","doi":"https://doi.org/10.3389/fimmu.2026.1844972","pmid":"https://pubmed.ncbi.nlm.nih.gov/42890256","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13672617"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2026.1844972","doi":"https://doi.org/10.3389/fimmu.2026.1844972","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1844972","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1844972/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W7216346331"],"child_works_count":1,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1844972/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079090688","display_name":"Vladimir Mulens\u2010Arias","orcid":"https://orcid.org/0000-0003-3549-0700","observed_orcids":["https://orcid.org/0000-0003-3549-0700"]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210089592","display_name":"Josep Carreras Leukaemia Research Institute","ror":"https://ror.org/00btzwk36","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210089592","https://openalex.org/I4210144824","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Vladimir Mulens-Arias","raw_affiliation_strings":["Josep Carreras Leukemia Research Institute (IJC), Barcelona, Spain","Red Espa\u00f1ola de Terapias Avanzadas (TERAV+), Instituto de Salud Carlos III, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Josep Carreras Leukemia Research Institute (IJC), Barcelona, Spain","institution_ids":["https://openalex.org/I4210089592"]},{"raw_affiliation_string":"Red Espa\u00f1ola de Terapias Avanzadas (TERAV+), Instituto de Salud Carlos III, Madrid, Spain","institution_ids":["https://openalex.org/I2801357902"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023076653","display_name":"Marco Archinti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Marco Archinti","raw_affiliation_strings":["ZIP Solutions SL., Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ZIP Solutions SL., Barcelona, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033244463","display_name":"Miriam Bastida","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Miriam Bastida","raw_affiliation_strings":["ZIP Solutions SL., Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ZIP Solutions SL., Barcelona, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072662677","display_name":"N\u00faria Mart\u00ednez","orcid":"https://orcid.org/0009-0007-2078-1499","observed_orcids":["https://orcid.org/0009-0007-2078-1499"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nuria Mart\u00ednez","raw_affiliation_strings":["ZIP Solutions SL., Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ZIP Solutions SL., Barcelona, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020552273","display_name":"Eleonora Pinto","orcid":"https://orcid.org/0000-0003-4955-5528","observed_orcids":["https://orcid.org/0000-0003-4955-5528"]},"institutions":[{"id":"https://openalex.org/I116067653","display_name":"University of Rome Tor Vergata","ror":"https://ror.org/02p77k626","country_code":"IT","type":"education","lineage":["https://openalex.org/I116067653"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Eleonora Pinto","raw_affiliation_strings":["Department of Clinical Sciences and Translational Medicine, Universityof Rome \u201cTor Vergata\u201d, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Sciences and Translational Medicine, Universityof Rome \u201cTor Vergata\u201d, Rome, Italy","institution_ids":["https://openalex.org/I116067653"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014993787","display_name":"V\u00edctor M. Diaz","orcid":"https://orcid.org/0000-0001-8561-7576","observed_orcids":["https://orcid.org/0000-0001-8561-7576"]},"institutions":[{"id":"https://openalex.org/I3123915005","display_name":"Universitat Internacional de Catalunya","ror":"https://ror.org/00tse2b39","country_code":"ES","type":"education","lineage":["https://openalex.org/I3123915005"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"V\u00edctor M. D\u00edaz","raw_affiliation_strings":["OneChain Immunotherapeutics SL., Barcelona, Spain","Universitat Internacional de Catalunya, Sant Cugat del Vall\u00e8s, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OneChain Immunotherapeutics SL., Barcelona, Spain","institution_ids":[]},{"raw_affiliation_string":"Universitat Internacional de Catalunya, Sant Cugat del Vall\u00e8s, Spain","institution_ids":["https://openalex.org/I3123915005"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5122345389","display_name":"Pablo Menendez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I11932220","display_name":"Instituci\u00f3 Catalana de Recerca i Estudis Avan\u00e7ats","ror":"https://ror.org/0371hy230","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I11932220"]},{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210089592","display_name":"Josep Carreras Leukaemia Research Institute","ror":"https://ror.org/00btzwk36","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210089592","https://openalex.org/I4210144824","https://openalex.org/I4387153040"]},{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]},{"id":"https://openalex.org/I4388446393","display_name":"Institut de Recerca Sant Joan de D\u00e9u","ror":"https://ror.org/00gy2ar74","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4388446393"]},{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Pablo Men\u00e9ndez","raw_affiliation_strings":["Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), Madrid, Spain","Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain","Instituci\u00f3 Catalana de Recerca i Estudis Avan\u00e7ats (ICREA), Barcelona, Spain","Institut de Recerca Hospital Sant Joan de D\u00e9u-Pediatric Cancer Center Barcelona (SJD-PCCB), Barcelona, Spain","Josep Carreras Leukemia Research Institute (IJC), Barcelona, Spain","Red Espa\u00f1ola de Terapias Avanzadas (TERAV+), Instituto de Salud Carlos III, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), Madrid, Spain","institution_ids":["https://openalex.org/I4210158561"]},{"raw_affiliation_string":"Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I71999127"]},{"raw_affiliation_string":"Instituci\u00f3 Catalana de Recerca i Estudis Avan\u00e7ats (ICREA), Barcelona, Spain","institution_ids":["https://openalex.org/I11932220"]},{"raw_affiliation_string":"Institut de Recerca Hospital Sant Joan de D\u00e9u-Pediatric Cancer Center Barcelona (SJD-PCCB), Barcelona, Spain","institution_ids":["https://openalex.org/I4388446393"]},{"raw_affiliation_string":"Josep Carreras Leukemia Research Institute (IJC), Barcelona, Spain","institution_ids":["https://openalex.org/I4210089592"]},{"raw_affiliation_string":"Red Espa\u00f1ola de Terapias Avanzadas (TERAV+), Instituto de Salud Carlos III, Madrid, Spain","institution_ids":["https://openalex.org/I2801357902"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5023076653"],"corresponding_institution_ids":[],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":"1844972","last_page":"1844972"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13326","display_name":"Biochemical and Structural Characterization","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10878","display_name":"CRISPR and Genetic Engineering","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/split-intein","display_name":"split intein","score":0.8579999804496765},{"id":"https://openalex.org/keywords/protein-trans-splicing","display_name":"protein trans-splicing","score":0.968999981880188},{"id":"https://openalex.org/keywords/chimeric-antigen-receptor","display_name":"chimeric antigen receptor","score":0.8109999895095825},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.9520000219345093},{"id":"https://openalex.org/keywords/cd1a","display_name":"CD1a","score":0.7039999961853027},{"id":"https://openalex.org/keywords/t-cell-acute-lymphoblastic-leukemia","display_name":"T-cell acute lymphoblastic leukemia","score":0.9850000143051147},{"id":"https://openalex.org/keywords/4-1bb","display_name":"4-1BB","score":0.9290000200271606},{"id":"https://openalex.org/keywords/cd3","display_name":"CD3","score":0.8629999756813049},{"id":"https://openalex.org/keywords/single-chain-variable-fragment","display_name":"scFv","score":0.753000020980835},{"id":"https://openalex.org/keywords/interferon-gamma-secretion","display_name":"interferon-gamma secretion","score":0.6000000238418579},{"id":"https://openalex.org/keywords/b-cell-malignancies","display_name":"B-cell malignancies","score":0.7310000061988831}],"concepts":[{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.71670001745224},{"id":"https://openalex.org/C183786373","wikidata":"https://www.wikidata.org/wiki/Q5964993","display_name":"Signal transducing adaptor protein","level":3,"score":0.5823000073432922},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.5130000114440918},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.43529999256134033},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.42080000042915344},{"id":"https://openalex.org/C54458228","wikidata":"https://www.wikidata.org/wiki/Q237218","display_name":"RNA splicing","level":4,"score":0.4065999984741211},{"id":"https://openalex.org/C194583182","wikidata":"https://www.wikidata.org/wiki/Q21114084","display_name":"Alternative splicing","level":4,"score":0.4032000005245209},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3986000120639801},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.38510000705718994},{"id":"https://openalex.org/C101468663","wikidata":"https://www.wikidata.org/wiki/Q1620158","display_name":"Modular design","level":2,"score":0.38370001316070557},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3808000087738037},{"id":"https://openalex.org/C147969180","wikidata":"https://www.wikidata.org/wiki/Q5014579","display_name":"CTL*","level":4,"score":0.35030001401901245},{"id":"https://openalex.org/C123894998","wikidata":"https://www.wikidata.org/wiki/Q425158","display_name":"Fusion protein","level":4,"score":0.34360000491142273},{"id":"https://openalex.org/C89429830","wikidata":"https://www.wikidata.org/wiki/Q735710","display_name":"Scaffold","level":2,"score":0.3183000087738037},{"id":"https://openalex.org/C3019111730","wikidata":"https://www.wikidata.org/wiki/Q159236","display_name":"Genetically engineered","level":3,"score":0.30889999866485596},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.3059999942779541},{"id":"https://openalex.org/C2779478453","wikidata":"https://www.wikidata.org/wiki/Q6889748","display_name":"Modularity (biology)","level":2,"score":0.3057999908924103},{"id":"https://openalex.org/C2780557392","wikidata":"https://www.wikidata.org/wiki/Q523796","display_name":"Linker","level":2,"score":0.296099990606308},{"id":"https://openalex.org/C116569031","wikidata":"https://www.wikidata.org/wiki/Q899107","display_name":"Ligand (biochemistry)","level":3,"score":0.289900004863739},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.289000004529953},{"id":"https://openalex.org/C147816474","wikidata":"https://www.wikidata.org/wiki/Q169525","display_name":"Protein engineering","level":3,"score":0.288100004196167},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.2847000062465668},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.27959999442100525},{"id":"https://openalex.org/C48209547","wikidata":"https://www.wikidata.org/wiki/Q1331104","display_name":"Controllability","level":2,"score":0.27559998631477356},{"id":"https://openalex.org/C157695867","wikidata":"https://www.wikidata.org/wiki/Q1100474","display_name":"B-cell receptor","level":4,"score":0.2752000093460083},{"id":"https://openalex.org/C174510640","wikidata":"https://www.wikidata.org/wiki/Q489618","display_name":"HEK 293 cells","level":3,"score":0.26969999074935913},{"id":"https://openalex.org/C30278631","wikidata":"https://www.wikidata.org/wiki/Q281721","display_name":"Chimera (genetics)","level":3,"score":0.2644999921321869}],"mesh":[{"descriptor_ui":"D000076962","descriptor_name":"Receptors, Chimeric Antigen","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D000076962","descriptor_name":"Receptors, Chimeric Antigen","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000076962","descriptor_name":"Receptors, Chimeric Antigen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D019154","descriptor_name":"Protein Splicing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047668","descriptor_name":"Inteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.3389/fimmu.2026.1844972","doi":"https://doi.org/10.3389/fimmu.2026.1844972","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1844972","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1844972/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13672617","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13672617/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13672617/pdf/fimmu-17-1844972.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmid:42890256","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42890256","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:6bb8453324404bce9337775a81e39c4b","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/6bb8453324404bce9337775a81e39c4b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2026.1844972","doi":"https://doi.org/10.3389/fimmu.2026.1844972","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1844972","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1844972/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2462415295","display_name":null,"funder_award_id":"13039/501100011033","funder_id":"https://openalex.org/F4320321505","funder_display_name":"Generalitat de Catalunya"},{"id":"https://openalex.org/G2767995713","display_name":null,"funder_award_id":"CPP2022-009759","funder_id":"https://openalex.org/F4320335322","funder_display_name":"European Regional Development Fund"},{"id":"https://openalex.org/G318412399","display_name":null,"funder_award_id":"13039/501100011033","funder_id":"https://openalex.org/F7311471023","funder_display_name":"NextGenerationEU"},{"id":"https://openalex.org/G410571670","display_name":null,"funder_award_id":"10.13039/501100011033","funder_id":"https://openalex.org/F4320335322","funder_display_name":"European Regional Development Fund"},{"id":"https://openalex.org/G4228227490","display_name":null,"funder_award_id":"MICIU/AEI/10","funder_id":"https://openalex.org/F4320321505","funder_display_name":"Generalitat de Catalunya"},{"id":"https://openalex.org/G451917667","display_name":null,"funder_award_id":"13039/501100011033","funder_id":"https://openalex.org/F4320335322","funder_display_name":"European Regional Development Fund"},{"id":"https://openalex.org/G4743485813","display_name":null,"funder_award_id":"PID2022-142966OB-I00","funder_id":"https://openalex.org/F4320335598","funder_display_name":"Agencia Estatal de Investigaci\u00f3n"},{"id":"https://openalex.org/G5967599077","display_name":null,"funder_award_id":"501100011033","funder_id":"https://openalex.org/F4320335322","funder_display_name":"European Regional Development Fund"},{"id":"https://openalex.org/G6033112984","display_name":null,"funder_award_id":"MICIU/AEI/10","funder_id":"https://openalex.org/F4320335322","funder_display_name":"European Regional Development Fund"},{"id":"https://openalex.org/G6520718613","display_name":null,"funder_award_id":"10.13039/501100011033","funder_id":"https://openalex.org/F7311471023","funder_display_name":"NextGenerationEU"},{"id":"https://openalex.org/G787121397","display_name":null,"funder_award_id":"MICIU/AEI/10.13039/501100011033/","funder_id":"https://openalex.org/F4320321505","funder_display_name":"Generalitat de Catalunya"},{"id":"https://openalex.org/G8716125719","display_name":null,"funder_award_id":"CPP2021-008676","funder_id":"https://openalex.org/F4320335322","funder_display_name":"European Regional Development Fund"}],"funders":[{"id":"https://openalex.org/F4320315803","display_name":"Centres de Recerca de Catalunya","ror":"https://ror.org/01bkbaq61"},{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320321505","display_name":"Generalitat de Catalunya","ror":"https://ror.org/01bg62x04"},{"id":"https://openalex.org/F4320334923","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886"},{"id":"https://openalex.org/F4320335322","display_name":"European Regional Development Fund","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320335598","display_name":"Agencia Estatal de Investigaci\u00f3n","ror":"https://ror.org/003x0zc53"},{"id":"https://openalex.org/F7311471023","display_name":"NextGenerationEU","ror":null}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7216346331.pdf","grobid_xml":"https://content.openalex.org/works/W7216346331.grobid-xml"},"referenced_works_count":24,"referenced_works":["https://openalex.org/W1964788865","https://openalex.org/W2125451007","https://openalex.org/W2917762074","https://openalex.org/W2968861805","https://openalex.org/W3012782981","https://openalex.org/W3166144051","https://openalex.org/W3211754161","https://openalex.org/W4322617577","https://openalex.org/W4387326873","https://openalex.org/W4389344785","https://openalex.org/W4394843957","https://openalex.org/W4396721167","https://openalex.org/W4398142342","https://openalex.org/W4401284904","https://openalex.org/W4403825098","https://openalex.org/W4405122984","https://openalex.org/W4409042647","https://openalex.org/W4411865404","https://openalex.org/W4412774970","https://openalex.org/W4414239957","https://openalex.org/W4415136672","https://openalex.org/W7125930958","https://openalex.org/W7127297410","https://openalex.org/W7203926483"],"related_works":["https://openalex.org/W4417022159","https://openalex.org/W4409042647","https://openalex.org/W3213927867","https://openalex.org/W4415136672","https://openalex.org/W2792959391","https://openalex.org/W7208721864","https://openalex.org/W6907812739","https://openalex.org/W3202809123","https://openalex.org/W2226275287","https://openalex.org/W6901859682"],"abstract_inverted_index":{"Introduction":[0],"Chimeric":[1],"antigen":[2,74],"receptor":[3,186],"(CAR)":[4],"T-cell":[5,41,77],"therapy":[6],"has":[7],"transformed":[8],"the":[9,18,91,118,128,131],"treatment":[10],"of":[11,22,62,85,109,127,145,162,185],"B-cell":[12],"malignancies.":[13],"However,":[14],"strategies":[15],"that":[16,169],"improve":[17],"modularity":[19],"and":[20,29,99,103,182],"controllability":[21],"CAR":[23,40,68,141,148,172,180],"signaling":[24,101],"could":[25],"broaden":[26],"its":[27],"applicability":[28],"safety":[30],"across":[31],"additional":[32],"clinical":[33],"contexts.":[34],"Here,":[35],"we":[36,64],"describe":[37],"a":[38,60,66,72,86,104,137,175],"regulable":[39],"platform":[42,177],"based":[43],"on":[44],"split":[45,67,94,122,170],"intein-mediated":[46,171],"protein":[47],"trans-splicing":[48],"(PTS)":[49],"to":[50,97,117,159],"conditionally":[51],"reconstitute":[52],"functional":[53,138],"receptors":[54],"in":[55,76],"primary":[56],"T-cells.":[57],"Methods":[58],"As":[59],"proof":[61],"concept,":[63],"engineered":[65],"targeting":[69],"CD1a":[70,140,154],"(NCT05679895),":[71],"surface":[73],"expressed":[75],"acute":[78],"lymphoblastic":[79],"leukemia":[80],"(T-ALL).":[81],"The":[82],"system":[83],"consists":[84],"membrane-anchored":[87],"C-terminal":[88],"scaffold":[89],"containing":[90],"IMPDH.1":[92,120],"C":[93],"intein":[95,132],"fused":[96,116],"4-1BB":[98],"CD3\u03b6":[100],"domains,":[102],"soluble":[105],"N-terminal":[106],"adaptor":[107,129],"composed":[108],"an":[110],"anti-CD1a":[111],"single-chain":[112],"variable":[113],"fragment":[114],"(scFv)":[115],"complementary":[119],"N":[121],"intein.":[123],"Results":[124],"Upon":[125],"delivery":[126],"module,":[130],"fragments":[133],"undergo":[134],"PTS,":[135],"generating":[136],"membrane-bound":[139],"with":[142],"splicing":[143],"efficiencies":[144],"85%.":[146],"Reconstituted":[147],"T-cells":[149],"exhibited":[150],"antigen-specific":[151],"cytotoxicity":[152],"against":[153],"+":[155],"T-ALL":[156],"cells":[157],"coupled":[158],"high":[160],"levels":[161],"interferon-\u03b3":[163],"secretion.":[164],"Discussion":[165],"These":[166],"findings":[167],"demonstrate":[168],"reconstitution":[173,181],"enables":[174],"modular":[176],"for":[178],"conditional":[179],"transient":[183],"control":[184],"availability.":[187]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7216346331","counts_by_year":[],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2026-10-03T00:00:00"}
